BioCentury
ARTICLE | Clinical News

eTag cancer data

November 21, 2005 8:00 AM UTC

In a study of 55 samples from NSCLC patients, the eTag assay could predict clinical response to Iressa treatment with 86% overall sensitivity and 79% positive predictive value. The assay analyzed epi...